Compare IRM & WAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IRM | WAT |
|---|---|---|
| Founded | 1951 | 1958 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Laboratory Analytical Instruments |
| Sector | Real Estate | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 32.6B | 32.7B |
| IPO Year | 1997 | 1996 |
| Metric | IRM | WAT |
|---|---|---|
| Price | $110.13 | $330.70 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 18 |
| Target Price | $112.25 | ★ $390.88 |
| AVG Volume (30 Days) | ★ 2.1M | 1.4M |
| Earning Date | 05-14-2026 | 05-11-2026 |
| Dividend Yield | ★ 3.13% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | 0.49 | ★ 7.00 |
| Revenue | ★ $4,491,531,000.00 | $2,958,387,000.00 |
| Revenue This Year | $12.67 | $103.90 |
| Revenue Next Year | $9.21 | $11.12 |
| P/E Ratio | $225.08 | ★ $47.62 |
| Revenue Growth | ★ 8.30 | N/A |
| 52 Week Low | $72.33 | $275.05 |
| 52 Week High | $111.63 | $414.15 |
| Indicator | IRM | WAT |
|---|---|---|
| Relative Strength Index (RSI) | 72.92 | 33.97 |
| Support Level | $96.83 | $281.33 |
| Resistance Level | N/A | $363.09 |
| Average True Range (ATR) | 3.63 | 12.78 |
| MACD | 1.22 | -1.82 |
| Stochastic Oscillator | 94.15 | 29.00 |
Iron Mountain Inc is an information management services provider organized and operated as a real estate investment trust. The company offers solutions to its clients to address their information management, digital transformation, information security, data center, and asset lifecycle management (ALM) needs. Its customers come from various industries, including commercial, legal, financial, healthcare, technology, etc. The company has two reportable segments: Global Records and Information Management (Global RIM) and Global Data Center. Maximum revenue is generated from the Global RIM segment, which offers data and records management, secure shredding, consumer storage, and other related services. Geographically, the company generates maximum revenue from the United States.
Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2024, Waters generated 58% from biopharmaceutical customers, 31% from industrial clients, and 11% from academic/government institutions. In early 2026, Waters plans to merge with BD's life science and diagnostics business, which will substantially change those concentrations. Waters will wind up with more concentration in diagnostics (versus none now) and discovery-related life science tools.